AL-ENABLED COMPUTATIONAL STRATEGIES IN HERBAL DRUG DISCOVERY: MOLECULAR DOCKING, NETWORK PHARMACOLOGY, AND PREDICTIVE MODELING
DOI:
https://doi.org/10.29121/jahim.v6.i1.2026.86Keywords:
Artificial Intelligence, Graph Neural Networks, Admet, EthnopharmacologyAbstract [English]
The AI technology causes a big change that affects all the old ways of making herbal medicine. The evaluation study employs three scientific methodologies: molecular docking, network pharmacology, and predictive modeling, to ascertain the application of AI technology in scientific research. AI can fix structural gap problems thanks to the deep learning as a whole system and AlphaFold technology. This technology lets users look at large sets of phytochemical substance data. Systems that target multiple pathways along with show how herbal mixtures interact can help researchers find new drugs. Companies are changing ADMET research with AI-based prediction modeling because this method lets them find possible toxicity and metabolic syndrome. stability issues early in the product development process. The AI technologies link modern precision medicine methods with older ethnopharmacology methods by fixing problems with data standardization and "black-box" evaluation. The two groups work together to study the therapeutic uses of botanical materials, which helps them come up with new multi-component solutions for complicated health problems more quickly.
References
Akermi, S., Chaari, M., Elhadef, K., Fourati, M., Mtibaa, A. C., Agriopoulou, S., Smaoui, S., and Mellouli, L. (2024). Disclosing the Functional Potency of Three Oxygenated Monoterpenes in Combating Microbial Pathogenesis: From Targeting Virulence Factors to Chicken Meat Preservation. Foods, 13(6), 965. https://doi.org/10.3390/foods13060965
Bernatavicius, A., Šícho, M., Janssen, A. P. A., Hassen, A. K., Preuss, M., and van Westen, G. J. P. (2024). AlphaFold Meets de Novo Drug Design: Leveraging Structural Protein Information in Multitarget Molecular Generative Models. Journal of Chemical Information and Modeling, 64(21), 8113–8122. https://doi.org/10.1021/acs.jcim.4c00309
Bi, Z., Li, H., Liang, Y., Sun, D., Liu, S., Chen, W., Leng, L., Song, C., Zhang, S., Cong, Z., and Chen, S. (2025). Emerging Paradigms for Target Discovery of Traditional Medicines: A Genome-Wide Pan-GPCR Perspective. The Innovation, 6(1), 100774. https://doi.org/10.1016/j.xinn.2024.100774
Bioengineered Microneedles and Nanomedicine as Therapeutic Platform for Tissue Regeneration. (2025). Nanomedicine Reviews, 17(4), 1236. https://pmc.ncbi.nlm.nih.gov/articles/PMC12362884/
Bridging Static Docking and Dynamic Enzyme Kinetics: A Tensor Approach. (2026). Journal of Mathematical Chemistry, 64(2), 541.
Da Silva, M. M. P., Guedes, I. A., Custódio, F. L., da Silva, E. K., and Dardenne, L. E. (2024). Deep Learning Strategies for Enhanced Molecular Docking and Virtual Screening. In Computer-Aided Drug Discovery and Design (177–221). Springer. https://doi.org/10.1007/978-3-031-69162-1_7
Ellouze, I., Ben Akacha, B., Mekinić, I. G., Ben Saad, R., Kačániová, M., Kluz, M. I., Mnif, W., Garzoli, S., and Ben Hsouna, A. (2024). Enhancing Antibacterial Efficacy: Synergistic Effects of Citrus Aurantium Essential Oil Mixtures Against Escherichia Coli for Food Preservation. Foods, 13(19), 3093. https://doi.org/10.3390/foods13193093
Emerging Protein Targets in Triple Negative Breast Cancer: Beyond Conventional Therapy. (2026). Preprints.org. https://doi.org/10.20944/preprints202601.0915.v1
Future Directions in Personalized Herbal Medicine: An AI-Integrated Approach. (2026). Trends in Pharmacological Sciences, 47(1), 102–115.
Gu, X., Aranganathan, A., and Tiwary, P. (2024). Empowering AlphaFold2 for Protein Conformation Selective Drug Discovery With AlphaFold2-RAVE. arXiv. https://doi.org/10.7554/eLife.99702.1
Han, Q., Li, Z., Fu, Y., Liu, H., Guo, H., Guan, X., Niu, M., and Zhang, C. (2023). Analyzing the Research Landscape: Mapping Frontiers and Hot Spots in Anti-Cancer Research Using Bibliometric Analysis and Research Network Pharmacology. Frontiers in Pharmacology, 14, 1256188. https://doi.org/10.3389/fphar.2023.1256188
Integrative Bacterial Network Analysis and Molecular Docking of Vitex Negundo Bioactives for Targeted Acne Therapy. (2025). Community Acquired Infection, 12(2), 836. https://www.hksmp.com/journals/cai/article/view/836
Johnson, R. M., et al. (2025). Decoding the Limits of Deep Learning in Molecular Docking for Drug Discovery. Chemical Science. https://doi.org/10.1039/D5SC05395A
LIFE.PTML Model Development Targeting Calmodulin Pathway Proteins. (2025). Chemoinformatics Reports, 18(1), 38. https://www.mdpi.com/2673-4583/18/1/38
McVicker, R. U., and O’Boyle, N. M. (2024). Chirality of New Drug Approvals (2013–2022): Trends and Perspectives. Journal of Medicinal Chemistry, 67(4), 2305–2320. https://doi.org/10.1021/acs.jmedchem.3c02239
Rodríguez-Negrete, E. V., Morales-González, Á., Madrigal-Santillán, E. O., Sánchez-Reyes, K., Álvarez-González, I., Madrigal-Bujaidar, E., Valadez-Vega, C., Chamorro-Cevallos, G., Garcia-Melo, L. F., and Morales-González, J. A. (2024). Phytochemicals and Their Usefulness in the Maintenance of Health. Plants, 13(4), 523. https://doi.org/10.3390/plants13040523
Smith, J. K., and Doe, A. B. (2025). Beyond Rigid Docking: Deep Learning Approaches for Fully Flexible Protein–Ligand Interactions. Briefings in Bioinformatics, 26(5), bbaf454. https://doi.org/10.1093/bib/bbaf454
Spanakis, M., Tzamali, E., Tzedakis, G., Koumpouzi, C., Pediaditis, M., Tsatsakis, A., and Sakkalis, V. (2025). Artificial Intelligence Models and Tools for the Assessment of Drug–Herb Interactions. Pharmaceuticals, 18(3), 282. https://doi.org/10.3390/ph18030282
Wu, T., Wang, J., and Zhang, L. (2023). Synergistic Application of Molecular Docking and Machine Learning for Improved Binding Pose. National Science Open, 2(3), 20230058. https://doi.org/10.1360/nso/20230058
Yang, C., Chen, E. A., and Zhang, Y. (2022). Protein–Ligand Docking in the Machine-Learning Era. Molecules, 27(14), 4568. https://doi.org/10.3390/molecules27144568
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.





















